Induction of Autophagy and Changes in Cellular Metabolism in Glucose Starved C2C12 Myotubes. 2020

Naoya Nakai, and Saki Kitai, and Noriko Iida, and Sachika Inoue, and Ken Nakata, and Taro Murakami, and Kazuhiko Higashida
Laboratory of Exercise Nutrition, Department of Nutrition, University of Shiga Prefecture.

Mouse myoblast C2C12 cells are commonly used as a model system for investigating the metabolic regulation of skeletal muscle. As it is therefore important to understand the metabolic features of C2C12 cells, we examined the effect of glucose starvation on autophagy in C2C12 myotubes. After culture of C2C12 myotubes with high (HG, 25.0 mM) or low (LG, 5.6 mM) glucose concentrations, the concentration of glucose in the LG group had decreased to 0 mM after 24 h of culture and was around 17 mM after 48 h of culture in the HG group. The concentration of lactate increased from 0 to approximately 9 mM at 24 h and then dropped slightly in the LG group, while it increased linearly to 21 mM in the HG group at 48 h. The phosphorylation of p70 S6 kinase, marker for the protein translation initiation was significantly lower and the ratio of LC3-II/LC3-I, marker for the induction of autophagy was significantly higher in the LG group. GLUT1 and hexokinase II expression were significantly higher in the LG group. Together, these changes in glucose and lactate concentrations in the culture media suggest that C2C12 myotubes depend on anaerobic glycolysis. Our findings also suggest that glucose depletion stimulates the expression of key molecules involved in glycolysis and that cellular autophagy is also activated in C2C12 myotubes.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006019 Glycolysis A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH. Embden-Meyerhof Pathway,Embden-Meyerhof-Parnas Pathway,Embden Meyerhof Parnas Pathway,Embden Meyerhof Pathway,Embden-Meyerhof Pathways,Pathway, Embden-Meyerhof,Pathway, Embden-Meyerhof-Parnas,Pathways, Embden-Meyerhof
D006593 Hexokinase An enzyme that catalyzes the conversion of ATP and a D-hexose to ADP and a D-hexose 6-phosphate. D-Glucose, D-mannose, D-fructose, sorbitol, and D-glucosamine can act as acceptors; ITP and dATP can act as donors. The liver isoenzyme has sometimes been called glucokinase. (From Enzyme Nomenclature, 1992) EC 2.7.1.1. Hexokinase A,Hexokinase D,Hexokinase II
D000597 Amino Acids, Branched-Chain Amino acids which have a branched carbon chain. Branched-Chain Amino Acid,Amino Acids, Branched Chain,Acid, Branched-Chain Amino,Acids, Branched-Chain Amino,Amino Acid, Branched-Chain,Branched Chain Amino Acid,Branched-Chain Amino Acids
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001343 Autophagy The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer. Autophagocytosis,ER-Phagy,Lipophagy,Nucleophagy,Reticulophagy,Ribophagy,Autophagy, Cellular,Cellular Autophagy,ER Phagy
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018485 Muscle Fibers, Skeletal Large, multinucleate single cells, either cylindrical or prismatic in shape, that form the basic unit of SKELETAL MUSCLE. They consist of MYOFIBRILS enclosed within and attached to the SARCOLEMMA. They are derived from the fusion of skeletal myoblasts (MYOBLASTS, SKELETAL) into a syncytium, followed by differentiation. Myocytes, Skeletal,Myotubes,Skeletal Myocytes,Skeletal Muscle Fibers,Fiber, Skeletal Muscle,Fibers, Skeletal Muscle,Muscle Fiber, Skeletal,Myocyte, Skeletal,Myotube,Skeletal Muscle Fiber,Skeletal Myocyte

Related Publications

Naoya Nakai, and Saki Kitai, and Noriko Iida, and Sachika Inoue, and Ken Nakata, and Taro Murakami, and Kazuhiko Higashida
December 2023, Journal of microbiology and biotechnology,
Naoya Nakai, and Saki Kitai, and Noriko Iida, and Sachika Inoue, and Ken Nakata, and Taro Murakami, and Kazuhiko Higashida
January 2019, Frontiers in physiology,
Naoya Nakai, and Saki Kitai, and Noriko Iida, and Sachika Inoue, and Ken Nakata, and Taro Murakami, and Kazuhiko Higashida
January 2013, PloS one,
Naoya Nakai, and Saki Kitai, and Noriko Iida, and Sachika Inoue, and Ken Nakata, and Taro Murakami, and Kazuhiko Higashida
February 2015, Scientific reports,
Naoya Nakai, and Saki Kitai, and Noriko Iida, and Sachika Inoue, and Ken Nakata, and Taro Murakami, and Kazuhiko Higashida
October 2006, American journal of physiology. Endocrinology and metabolism,
Naoya Nakai, and Saki Kitai, and Noriko Iida, and Sachika Inoue, and Ken Nakata, and Taro Murakami, and Kazuhiko Higashida
January 2015, Evidence-based complementary and alternative medicine : eCAM,
Naoya Nakai, and Saki Kitai, and Noriko Iida, and Sachika Inoue, and Ken Nakata, and Taro Murakami, and Kazuhiko Higashida
July 2017, Acta pharmaceutica Sinica. B,
Naoya Nakai, and Saki Kitai, and Noriko Iida, and Sachika Inoue, and Ken Nakata, and Taro Murakami, and Kazuhiko Higashida
September 2014, The international journal of biochemistry & cell biology,
Naoya Nakai, and Saki Kitai, and Noriko Iida, and Sachika Inoue, and Ken Nakata, and Taro Murakami, and Kazuhiko Higashida
April 2015, Biochemical and biophysical research communications,
Naoya Nakai, and Saki Kitai, and Noriko Iida, and Sachika Inoue, and Ken Nakata, and Taro Murakami, and Kazuhiko Higashida
April 2024, Biochimie,
Copied contents to your clipboard!